COVID 19 and Other Coronaviruses
COVID-19 changed medicine and public health around the world. Coronaviruses, including SARS-CoV-2, SARS and MERS, continue to circulate and evolve, and lessons from the pandemic are shaping how we prepare for future threats.
The COVID 19 and Other Coronaviruses session at Infectious 2027 covers clinical care, research and public health lessons. It connects closely with advances in viral infections, which looks at progress across many viral diseases.
COVID-19 showed how quickly a new virus can affect health, economies and daily life worldwide. It also led to rapid advances in vaccines, testing and treatment. SARS-CoV-2 continues to circulate and change. Other coronaviruses, such as MERS, remain a concern in some regions.
Key Topics in COVID 19 and Other Coronaviruses
• SARS-CoV-2 variants and evolution
• Clinical management of COVID-19
• Long COVID and post-acute conditions
• COVID-19 vaccines and boosters
• Antiviral treatments
• MERS and other zoonotic coronaviruses
• COVID-19 in high-risk groups
• Health system lessons from the pandemic
• Coronavirus surveillance
• Pandemic preparedness for coronaviruses
Recent Advances in COVID 19 and Other Coronaviruses
SARS-CoV-2 continues to evolve, and updated vaccines, discussed in vaccine development and immunization, are being developed to match new variants. Research on long COVID is identifying possible causes and treatments for people with lasting symptoms.
COVID-19 had a heavy impact on older adults, a focus of geriatric infectious diseases. The pandemic also highlighted the mental health toll of infection and isolation, explored in psychosocial aspects of infectious disease management.
Updated vaccines and antivirals are helping protect people at higher risk. Research on long COVID is improving understanding of lasting symptoms and how to support patients. Studies are reviewing which public health measures worked best. Coronavirus surveillance in animals is helping watch for new threats.
Who Should Attend the COVID 19 and Other Coronaviruses Session
• Infectious disease and respiratory physicians
• Virologists and immunologists
• Public health professionals
• Critical care and hospital staff
• PhD students and early-career researchers
• Vaccine and antiviral researchers
Why Present Your Research in COVID 19 and Other Coronaviruses
Presenting at Infectious 2027 lets you share COVID-19 research and lessons with an international audience. You can connect with colleagues in emerging and re emerging infectious diseases preparing for the next pandemic. The pandemic produced a large body of research and experience. Presenting here helps turn these lessons into better preparedness.
Frequently Asked Questions
Can I present long COVID research?
Yes. Long COVID and post-acute conditions are key topics.
Does this session include MERS?
Yes. Research on MERS and other coronaviruses is welcome.
Where is Infectious 2027 held?
Infectious 2027 is held at Village Hotel Changi, Singapore, from 11 to 13 March 2027, with an online option.